Eptacog Alfa

Records for this ingredient, by country (identity only).

ATC B02BD08 · 7 markets · 23 records

Eptacog Alfa 7 markets · 23 records Forms
Filters
MarketAU 5FR 4ES 3JP 3SG 2HK 2TW 1
Kind

AU 5 records · 4 shown of 4 Source TGA、TGA CMI repository (consumer medic · Data as of 2026-10-28、live · some records have no stated strength · includes records with unknown status (not proof of sale)

Combination products containing this ingredient

  • 8 mg per mL / per unit basis not statedinjection CombinationEptacog Alfa 8 mg + Histidine 12.57 mgNOVOSEVEN RT eptacog alfa (activated) (bhk) 1mg powder for injection vial with pre-filled diluent syringe unknown
  • 5 mg per mL / per unit basis not statedinjection CombinationEptacog Alfa 5 mg + Histidine 8.01 mgNOVOSEVEN RT eptacog alfa (activated) (bhk) 1mg powder for injection vial with pre-filled diluent syringe unknown
  • 2 mg per mL / per unit basis not statedinjection CombinationEptacog Alfa 2 mg + Histidine 3.26 mgNOVOSEVEN RT eptacog alfa (activated) (bhk) 1mg powder for injection vial with pre-filled diluent syringe unknown
  • 1 mg per mL / per unit basis not statedinjection CombinationEptacog Alfa 1 mg + Histidine 1.74 mgNOVOSEVEN RT eptacog alfa (activated) (bhk) 1mg powder for injection vial with pre-filled diluent syringe unknown
1 records · 0 manufacturers 1 registros · 0 fabricantes 1 个记录 · 0 个厂家 1 個記錄 · 0 個廠商
With a brand name Con nombre comercial 有商品名 有商品名NovoSeven RT ×1

Full list in the data package Lista completa en el paquete de datos 完整清单见数据包 完整清單見資料包

FR 4 records · 4 shown of 4 Source Base de données publique des médic · Data as of 2026-11-03

Only this ingredient

  • 2 mg per mL / per unit basis not statedinjectionNOVOSEVEN 2 mg (100 KUI), poudre et solvant pour solution injectable
  • 1 mg per mL / per unit basis not statedinjectionNOVOSEVEN 1 mg (50 KUI), poudre et solvant pour solution injectable
  • 5 mg per mL / per unit basis not statedinjectionNOVOSEVEN 5 mg (250 KUI), poudre et solvant pour solution injectable
  • 8 mg per mL / per unit basis not statedinjectionNOVOSEVEN 8 mg (400 KUI), poudre et solvant pour solution injectable

ES 3 records · 3 shown of 3 Source CIMA (AEMPS) · Data as of live

Only this ingredient

JP 3 records · 3 shown of 3 Source 厚生労働省 薬価基準収載品目リスト · Data as of 2026-11-01

Only this ingredient

SG 2 records · 2 shown of 2 Source Health Sciences Authority (HSA) · Data as of 2026-08-07

Only this ingredient

HK 2 records · 0 shown of 0 Source 衞生署藥物辦公室（香港）註冊藥劑製品名單 · Data as of 2026-10-23 · some records have no stated strength · includes records with unknown status (not proof of sale)

2 records · 0 manufacturers 2 registros · 0 fabricantes 2 个记录 · 0 个厂家 2 個記錄 · 0 個廠商
With a brand name Con nombre comercial 有商品名 有商品名NOVOSEVEN POWDER AND SOLVENT FOR INJ 1MG ×4

Full list in the data package Lista completa en el paquete de datos 完整清单见数据包 完整清單見資料包

TW 1 records · 0 shown of 0 Source 衛生福利部食品藥物管理署（TFDA）全部藥品許可證資料集 · Data as of 2026-10-22 · some records have no stated strength

1 records · 0 manufacturers 1 registros · 0 fabricantes 1 个记录 · 0 个厂家 1 個記錄 · 0 個廠商
With a brand name Con nombre comercial 有商品名 有商品名NovoSeven RT ×1諾和第七因子室溫注射劑 ×1

Full list in the data package Lista completa en el paquete de datos 完整清单见数据包 完整清單見資料包

Some strengths are recorded without a per mL / per unit basis. They are shown as recorded and are not compared with other markets.

The same ingredient can carry completely different brand names in different countries, and the same name can point to a different ingredient. Listed by country — not interchangeable.

Discontinued, withdrawn or unverified-status products are hidden by default; Hong Kong and Australia records are shown as exceptions.

A side-by-side table is offered only when this ingredient has records in many markets; otherwise this list is the whole picture.